Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer
Status:
Terminated
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Ketoconazole may suppress the production of hormones and may interfere in the
growth of prostate cancer cells. Alendronate sodium may be effective in preventing bone
metastases and bone pain associated with prostate cancer. It is not known if ketoconazole is
more effective with or without alendronate sodium.
PURPOSE: Randomized phase II trial to study the effectiveness of ketoconazole with or without
alendronate sodium in treating patients who have metastatic prostate cancer.